- Home
- TME vs SNN Comparison
TME vs SNN Comparison
Compare TME & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TME | SNN |
|---|---|---|
| Founded | N/A | 1856 |
| Country | China | United Kingdom |
| Employees | 5353 | 16988 |
| Industry | Broadcasting | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 14.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TME | SNN |
|---|---|---|
| Price | $10.12 | $34.15 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 2 |
| Target Price | $19.44 | ★ $36.25 |
| AVG Volume (30 Days) | ★ 9.5M | 736.5K |
| Earning Date | 05-12-2026 | 03-16-2026 |
| Dividend Yield | ★ 2.38% | 2.19% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.73 | $8.58 |
| Revenue Next Year | $10.19 | $5.60 |
| P/E Ratio | ★ $15.69 | $64.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.78 | $26.02 |
| 52 Week High | $26.70 | $38.79 |
Technical Indicators
Market Signals| Indicator | TME | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 42.83 | 57.17 |
| Support Level | $8.78 | $32.03 |
| Resistance Level | $18.83 | $37.23 |
| Average True Range (ATR) | 0.25 | 0.57 |
| MACD | 0.31 | 0.28 |
| Stochastic Oscillator | 91.50 | 83.48 |
Price Performance
Historical ComparisonAbout TME Tencent Music Entertainment Group each representing two
Tencent Music is the largest online music streaming platform in China, established in 2016 through the merger of QQ Music, Kuwo Music, and Kugou Music. Tencent, its largest shareholder, holds over 50% of the shares and more than 90% of the voting rights. Beyond streaming services, Tencent Music generates revenue through a diverse range of offerings, including podcasts, livestreaming, concerts, and karaoke.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.